Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

News of the day

Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Cardiovascular LLC

2nd September 2008 ANN ARBOR, Michigan, September 2 /PRNewswire/ -- Terumo Cardiovascular Systems (Terumo CVS) announced that it filed a patent infringement complaint on August 21 in the Northern District of California against Maquet Cardiovascular LLC. The complaint alleges that Maquet's Vasoview(R) Endoscopic Vessel Harvesting Systems infringe a patent for which Terumo CVS owns the rights. The complaint also requests an injunction against further sales of the product in the U.S. (Logo:... more

Intellect Neurosciences, Inc. Obtains Pivotal European Patent Related To Monoclonal Antibody Passive Immunization Treatment Of Alzheimer's Disease

31st July 2008 NEW YORK, July 31 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) announced today it has obtained a European patent relating to the Company's ANTISENILIN(R) monoclonal antibody platform for the treatment of Alzheimer's disease. The claims of the issued patent cover the ANTISENILIN(R) "free-end specific" antibodies that bind to beta amyloid and use of the antibodies in preventing or inhibiting the progression of Alzheimer's disease. The technology is designed to promote... more

Nventa Wins European Patent Challenge Covering Lead Product Candidate HspE7 and Other HPV Therapeutics

29th July 2008 SAN DIEGO, July 29 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today that it has received a favorable decision from the Technical Board of Appeal of the European Patent Office (EPO) for the company's European Patent Number 1,002,110. This patent, which allows exclusively through 2018, covers compositions of fusion proteins comprised of a human papillomavirus (HPV) antigen fused to a heat shock protein (Hsp), as well as DNA encoding such fusion proteins. This... more
Patent Law RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
Category
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

More recent news

Solianis' Novel Multisensor Technology Monitors Hydration Changes in Skin - Two Patents Submitted Opening New Horizons for Cosmetic Manufacturers and Customers
24th July 2008 ZURICH, Switzerland, July 24 /PRNewswire/ -- Solianis' new patents cover the basic technology to monitor changes in the hydration of skin at different depths and to evaluate the impact of cosmetic...

Silence Therapeutics Announces Successful Opposition of Glover Patent
11th July 2008 LONDON, July 11 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN), a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a...

Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
19th June 2008 SUNNYVALE, California, June 19 /PRNewswire/ -- Artecel, Inc., announced today that the patent inventorship litigation concerning the foundational, composition-of-matter patent covering stem...

Oncolytics Biotech Inc. Announces Issuance of 27th U.S. Patent
20th May 2008 CALGARY, Canada, May 20 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted U.S. Patent 7,374,752 entitled "Reovirus for the...

Neuralstem Goes to Court for Summary Judgment Against StemCells, Inc.
6th May 2008 ROCKVILLE, Maryland, May 6 /PRNewswire/ -- Stem cell company, Neuralstem, Inc. (Amex: CUR), today announced that they have filed a motion to re-open the infringement lawsuit with StemCells, Inc. and...

Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
17th April 2008 JENA, Germany, April 17 /PRNewswire/ -- Occlutech GmbH, the leading European manufacturer of cardiac occlusion devices today announced a clarification of a recent news release. In a news release...

Neptune Technologies Patent Granted for Novel Phospholipids in Multiple Diseases and Pharmaceutical Applications
27th March 2008 LAVAL, Canada, March 27 /PRNewswire/ -- Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ: NEPT - TSX.V.NTB) announces that the European Patent Office (EPO) granted on May 31st 2007...

Partnering consultation free of charge
Maximizing Pharmaceutical Patent Lifecycles
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us